ÂÜÀòÂÒÂ×

David Malliaros is a seasoned consultant in the biopharmaceutical sector, currently serving at Syner-G BioPharma Group since March 2022 and at D. Malliaros Consulting, LLC since June 2020. With extensive experience in quality control and analytical operations, David held senior roles at Ultragenyx Gene Therapy as Senior Director of Quality Control and at Ironwood Pharmaceuticals as Director of Analytical Technical Operations. Previous positions include Director of Quality Control & Analytical Technology at Olympus Biotech and Associate Director at Stryker Biotech. David's career began at Biogen Idec as a Principal Scientist, where significant contributions were made to the Analytical Technology group and quality management of Avonex. David holds a Ph.D. in Biochemistry from the University of Massachusetts Lowell and a BS in Zoology from the University of Massachusetts Amherst.